Enlimomab (BI-RR 0001), a murine IgG2a monoclonal antibody targeting human ICAM-1, reduces leukocyte adhesion to the vascular endothelium, thus diminishing leukocyte extravasation and inflammatory tissue damage. This compound exhibits anti-inflammatory p
CAS Number:
[142864-19-5]
* VAT and and shipping costs not included. Errors and price changes excepted
